Survival rates for idiopathic pulmonary fibrosis are worse than all solid cancers except for lung and pancreatic cancer. | ...

Insilico Medicine plans to push its computer-designed drug into pivotal clinical trials after a phase 2a study demonstrated ...

In a small Phase IIa trial, Insilico’s generative AI-designed idiopathic pulmonary fibrosis drug improved lung function and ...

The development of a novel, artificial intelligence (AI)-generated biotechnology has the potential to transform care options ...

This is also true for intrinsic restrictive lung diseases like pneumonia. Other conditions can be harder to treat. For example, until recently, there was little that could be done to treat idiopathic ...

Patients were excluded if they had any of the following: known congenital lung disease; mental or cognitive impairment; use ...

Mutant RAS, they ... Oct. 31, 2024 — Researchers have shown that the IGFBP3 protein plays a relevant role in human lung development. The results of the study, which used organoids derived from ...

The assessment of patients with non-neoplastic lung diseases requires a multidisciplinary approach with evaluation of clinical, radiologic, and pathologic parameters. This chapter will review ...

ARP Atlases. 2007;1:17-47. The total number of leukocytes recovered by lavage is determined by examination of a sample of the pooled fluid with a hemocytometer. The cell counts are most accurate ...

A solitary pulmonary nodule (SPN) is an isolated lung growth surrounded by normal tissue. Most SPNs are benign (not cancerous) when they're diagnosed. However, some nodules can enlarge and change over ...

Developed by the American Lung Association in partnership with the Prevention Research Center of West Virginia University, this new free education program is available for any school or community to ...

Never did I imagine I would have a double-lung transplant in 2014 and eight months later pick ... This site contains general information about cystic fibrosis, as well as personal insight from the CF ...